2389-60-8|N-Cbz-N'-Boc-L-lysine - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

N-Cbz-N'-Boc-L-lysine | CAS:2389-60-8

N-Cbz-N'-Boc-L-lysine

Name：N-Cbz-N'-Boc-L-lysine
CAS：2389-60-8
Synonyms：N-(Benzyloxycarbonyl)-N'-(tert-butoxycarbonyl)-L-lysine; N'-(tert-Butoxycarbonyl)-N-carbobenzoxy-L-lysine
Molecular Formula：C₁₉H₂₈N₂O₆
Molecular Weight：380.43
EINESC：219-223-1

Description

Properties

没有数据	没有数据

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
Alfa-Aesar	View & Download
TCI	View & Download
Matrix	View & Download

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Ligustilide attenuates pain behavior induced by acetic acid or formalinDu J, et al. Journal of Ethnopharmacology, 112(1), 211-214 (2007) Pharmacokinetics and Metabolism of Ligustilide, a Major Bioactive Component in Rhizoma Chuanxiong, in the RatYan R, et al. Drug Metabolism and Disposition (2007) Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Kuang X, et al. Free Radical Biology & Medicine, 71, 165-175 (2014)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News